Endobronchial Ultrasound Biopsy Market Size, Trends, and Strategic Outlook 2026-2033

Market Size and Overview

The Global Endobronchial Ultrasound Biopsy Market size is estimated to be valued at USD 1.48 billion in 2026 and is expected to reach USD 3.12 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033.

The market revenue growth is supported by rising awareness of lung cancer screening and expanding adoption across emerging markets. Increasing reimbursement policies and technological advancements in ultrasound biopsy probes are further driving the market scope. Market insights reveal consistent growth in hospital-based endoscopy units, contributing substantially to industry size and Endobronchial Ultrasound Biopsy Market Growth gains.

Current Event & Its Impact on Market

I. Technological Advancements and Regulatory Approvals in Asia-Pacific

A. Emergence of Portable EBUS Systems in China – Potential impact on Market: The launch of compact, portable endobronchial ultrasound biopsy devices by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. in 2025 has facilitated wider adoption in semi-urban hospitals, improving market penetration in nano-level regions.

B. Regulatory Streamlining in Japan – Potential impact on Market: Faster FDA-equivalent approvals have accelerated device availability, enhancing business growth and market revenue in matured Asian markets.

C. Rising Investment in Hospital Upgrades – Potential impact on Market: Economic incentives from government healthcare modernization policies boost equipment purchases, positively influencing the market size and forecast within the Asia-Pacific segment.

II. US-China Trade Dynamics and Supply Chain Disruptions

A. Tariffs on Medical Devices – Potential impact on Market: Increased import tariffs on components have temporarily escalated production costs for devices imported into the US, affecting profit margins of key market players and slowing supply chain velocity.

B. Shift Toward Regional Manufacturing Hubs – Potential impact on Market: Companies like Veran Medical Technologies are expanding manufacturing footprints within the US and Europe to mitigate geopolitical risks, supporting supply chain resiliency and steady market share retention.

C. Growing Demand in North America for Early Lung Cancer Detection – Potential impact on Market: Despite geopolitical tensions, increasing pulmonary disease incidence drives surging demand, thus supporting steady market growth strategies.

Impact of Geopolitical Situation on Supply Chain

A notable example is the ripple effect caused by the US-China geopolitical tensions, which heightened tariffs and regulatory scrutiny on electronic components essential for endobronchial ultrasound biopsy devices. Veran Medical Technologies reported extended lead times during 2024, impacting the supply of critical ultrasound transducers. As an adaptive measure, the company diversified its supplier base by establishing partnerships in Southeast Asia, stabilizing supply chain operations and mitigating risks associated with dependency on a single region. This geopolitical-induced supply chain recalibration underscores market dynamics related to market revenue fluctuations and supply disruptions in the endobronchial ultrasound biopsy market.

SWOT Analysis

Strengths:

- Robust innovation pipeline with enhanced imaging technology improving diagnostic accuracy.

- Strong market share by established players like Pentax Medical and KARL STORZ, leveraging extensive distribution networks.

- Growing reimbursement landscape enabling increased procedure adoption.

Weaknesses:

- High device and procedural costs limiting access in low-income regions.

- Complex regulatory pathways causing delays in product launches in certain geographies.

- Limited patient awareness hindering market penetration on a broader scale.

Opportunities:

- Increasing prevalence of lung cancer globally driving demand for early diagnostic tools.

- Expansion into emerging markets with rising healthcare infrastructure investments.

- Integration of AI and machine learning to enhance image interpretation and market growth strategies.

Threats:

- Supply chain disruptions linked to geopolitical tensions affecting timely delivery of critical components.

- Competition from alternative diagnostic procedures such as navigational bronchoscopy.

- Regulatory uncertainties, especially in developing regions, may restrain rapid market revenue growth.

Key Players

- Veran Medical Technologies

- Pentax Medical

- Fuji Systems Corp

- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

- Ambu A/S

- Getinge AB

- KARL STORZ SE & Co. KG

- Merit Medical Systems Inc.

- Invivo Corporation

In 2024, Ambu A/S initiated strategic technology partnerships to develop single-use ultrasound bronchoscopes, reducing cross-contamination risks and expanding market share in the hospital segment. Similarly, in 2025, Pentax Medical invested heavily in AI-driven imaging software, enhancing biopsy procedure accuracy and leading to measurable improvements in end-user satisfaction and market revenue growth. Meanwhile, Getinge AB expanded manufacturing capabilities in Europe, aimed at bolstering supply chain security amid geopolitical uncertainties, thereby sustaining its industry size leadership.

FAQs

1. Who are the dominant players in the Endobronchial Ultrasound Biopsy market?

The market is led by companies such as Veran Medical Technologies, Pentax Medical, KARL STORZ SE & Co. KG, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd., known for their robust portfolios and technology-driven innovations.

2. What will be the size of the Endobronchial Ultrasound Biopsy market in the coming years?

The market size is estimated to grow from USD 1.48 billion in 2026 to USD 3.12 billion by 2033, with a CAGR of 11%, driven by advancements in diagnostic technologies and rising demand for minimally invasive lung biopsies.

3. Which end-user segment has the largest growth opportunity?

Hospital-based endoscopy and pulmonary care centers remain the largest end-user segments, benefiting from increasing procedures for lung cancer diagnosis and governmental healthcare investments.

4. How will market development trends evolve over the next five years?

Market trends indicate accelerated integration of AI technologies, increased portable device launches, and expansion into emerging healthcare markets, all propelling sustained market growth.

5. What is the nature of the competitive landscape and challenges in the Endobronchial Ultrasound Biopsy market?

The landscape is competitive, with established market players focusing on R&D and partnerships. Challenges include regulatory complexities and cost constraints, which companies are addressing through innovation and supply chain diversification.

6. What go-to-market strategies are commonly adopted in the Endobronchial Ultrasound Biopsy market?

Strategies focus on technological collaborations, targeted regional expansions, customization of products for specific markets, and strengthening distribution networks to maximize market opportunities and revenue streams.

➣ Get more insights on: Endobronchial Ultrasound Biopsy Market

➣ Get this Report in Japanese Language: 気管支内超音波生検市場

➣ Get this Report in Korean Language: 기관지내초음파생검시장

➣ Read More Related Articles: The Angelina Jolie effect: Consumer Health Awareness Spurring the Growth of Automated Breast Ultrasound Market

About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.